Life sciences
Shifting demographics. Shrinking margins. Evolving regulations. Rising R&D costs. There is little doubt that life sciences companies face a range of significant challenges for the years ahead. To adapt effectively, pharmaceutical, medical devices and biotechnology organizations must not only accelerate their development processes, they must also re-examine their underlying operational strategies.
Deloitte’s professionals have experience working with life sciences companies across the country to enhance revenues, manage costs and improve asset turnover. Our industry specialists can help you refine your business models through innovative partnerships, improved processes and more effective compliance — ultimately strengthening both patient care and stakeholder value.
 |
Helping Canada’s biopharmaceutical companies compete "Take the lead" explores the challenges facing the biopharmaceutical industry and identifies global best practices Canadian organizations can adopt to enhance their competitive positioning. |
Related links
 |
2011 Canadian consumer health survey View archive |
 |
Convergence in the Life Sciences industry A Deloitte Research report |
Featured content
© Deloitte LLP and affiliated entities.
Ⓜ Official Mark of the Canadian Olympic Committee.
Audit, Consulting, Tax, Financial Advisory Professional Services